North American stocks encountered turbulence in late February and early March. Rising bond yields led to severe volatility in the technology space, plunging some top tech stocks into bear market territory. However, the passing of the $1.9 trillion U.S. stimulus package has reinvigorated markets. Optimism has returned, but there are still discounts available from the quick correction. Today, I want to look at my favourite TSX stocks that are priced under the $15 mark.
Why BlackBerry deserves your attention today
BlackBerry (TSX:BB)(NYSE:BB) stock has been on a roller-coaster ride over the past month. The stock was impacted by the GameStop trade that saw retail investors flood into BlackBerry, AMC Entertainment, and Nokia on hopes that they could stage a populist rally. Shares of BlackBerry rose to a 52-week high of $36, but that momentum dried up swiftly. Still, the TSX stock is up 59% in 2021 as of early afternoon trading on March 11.
Investors can expect to see its first-quarter results in the first day of summer. BlackBerry drew attention when it announced a collaboration with Amazon back in December 2020 to development automobile software. This technology will hit the market by 2023.
BlackBerry is still behind the top names in the cybersecurity and automobile software space, but it has made some promising strides in recent years. This TSX stock is worth a look and is trading at $13.42 per share at the time of this writing.
This TSX stock is geared up for big growth this decade
The COVID-19 pandemic has tested healthcare systems all over the world. More than that, it has transformed healthcare services. Telehealth, the use of digital information and communication technologies to access healthcare services remotely, has erupted over the past year. WELL Health Technologies (TSX:WELL) has posted record results on the back of this transformation.
Shares of WELL Health have climbed 432% from the prior year. The stock was last priced at $8.31 per share. WELL Health will gain greater access to the U.S. market after its acquisition of CRH Medical. This TSX stock belongs in your portfolio for the long term.
Another healthcare stock to snag for the long haul
VieMed Healthcare (TSX:VMD)(NASDAQ:VMD) is another healthcare stock that has surged during the COVID-19 pandemic. Its shares have climbed 195% year over year. VieMed provides equipment and home therapy to service patients with various respiratory diseases. The company offered to aid in providing ventilators at the height of the COVID-19 pandemic.
It released its fourth-quarter and full-year 2020 results on March 3. Net revenues rose 22% year over year to $26.1 million. Meanwhile, adjusted EBITDA jumped 70% to $9.5 million. VieMed still expects the pandemic to bolster revenues by $2.3 million to $3.3 million in the first quarter of 2021. Better yet, this TSX stock last had a favourable price-to-earnings ratio of 12. The stock last traded at a price of $12.57 per share.
Rising steel prices have spurred this TSX stock in 2021
Optimism for a global economic rebound has sparked a run for commodities around the world. Copper, lumber, steel, and other prices have surged in recent months. Tree Island Steel (TSX:TSL) has been a beneficiary of this trend. Its shares have increased 9.4% in 2021 so far. The stock is up 72% year over year.
Tree Island released its last batch of 2020 results on March 4. Revenues rose $15.5 million year over year to nearly $216 million. Meanwhile, gross profit climbed from $17.8 million to $25.9 million. Shares of this TSX stock possess a solid P/E ratio of 16. Moreover, Tree Island offers a quarterly dividend of $0.03 per share. That represents a 4.1% yield. The stock was worth $2.91 at the time of this writing.
Here are five more stocks to snatch up right now...
Motley Fool Canada's market-beating team has just released a brand-new FREE report revealing 5 "dirt cheap" stocks that you can buy today for under $49 a share.
Our team thinks these 5 stocks are critically undervalued, but more importantly, could potentially make Canadian investors who act quickly a fortune.
Don't miss out! Simply click the link below to grab your free copy and discover all 5 of these stocks now.
This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.
John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Amazon and Viemed Healthcare Inc. The Motley Fool recommends BlackBerry and BlackBerry and recommends the following options: long January 2022 $1920 calls on Amazon and short January 2022 $1940 calls on Amazon.